2-Ethenyl-3,5-dimethylpyrazine
Common Name: |
2-Ethenyl-3,5-dimethylpyrazine |
IUPAC Name: |
2-ethenyl-3,5-dimethylpyrazine |
Molecular Formula: |
C8H10N2 |
SMILES: |
CC1=CN=C(C(=N1)C)C=C |
Inchi: |
1S/C8H10N2/c1-4-8-7(3)10-6(2)5-9-8/h4-5H,1H2,2-3H3 |
Inchi Key: |
ZUOLEJGELMNGPM-UHFFFAOYSA-N |
Cas No: |
157615-33-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
134.18 |
Mass (g/mol) |
134.084 |
Molar Refractivity |
42.05 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
25.78 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
183.00 to 184.00 |
Vapor Pressure (mmHg@25.00 °C) |
1.034 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.25 |
LogP |
1.736 |
iLOGP |
1.97 |
XLOGP3 |
1.36 |
WLOGP |
1.63 |
MLOGP |
0.46 |
ESOL Log S |
-1.91 |
ESOL Solubility (mg/ml) |
1.66 |
ESOL Solubility (mol/l) |
0.012 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.50 |
Ali Solubility (mg/ml) |
4.21 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.84 |
Silicos-IT Solubility (mg/ml) |
0.19 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.15 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.702 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.46 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |